Signaling mechanisms, interaction partners, and target genes of STAT6

Cytokine and Growth Factor Reviews

Volumn 17, Issue 3, 2006, Pages 173-188

  Hebenstreit, Daniel ^a   Wirnsberger, Gerald ^a   Horejs Hoeck, Jutta ^a   Duschl, Albert ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

Author keywords

IL 13; IL 4; STAT6; TH2; Transcription factor

Indexed keywords

CHEMOKINE; CYTOKINE RECEPTOR; GLUCOCORTICOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLATELET DERIVED GROWTH FACTOR; STAT6 PROTEIN; TRANSCRIPTION FACTOR;

ACETYLATION; ALLERGY; B CELL LYMPHOMA; BINDING SITE; CD4+ T LYMPHOCYTE; CHROMOSOME; CHROMOSOME 10; DNA BINDING; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE STRUCTURE; HEART; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; INFLAMMATION; KNOCKOUT MOUSE; LUNG; MAST CELL; MOUSE STRAIN; NEMATODE; NEMATODIASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; DNA; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 33744546660     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2006.01.004     Document Type: Review

References (182)

1. Horvath C.M. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25 10 (2000) 496-502
2. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3 9 (2002) 651-662
3. Boothby M., Gravallese E., Liou H.C., and Glimcher L.H. A DNA binding protein regulated by IL-4 and by differentiation in B cells. Science 242 4885 (1988) 1559-1562
4. Kotanides H., and Reich N.C. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262 5137 (1993) 1265-1267
5. Kohler I., and Rieber E.P. Allergy-associated I epsilon and Ec epsilon receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element. Eur J Immunol 23 12 (1993) 3066-3071
6. Schindler C., Kashleva H., Pernis A., Pine R., and Rothman P. STF-IL-4: a novel IL-4-induced signal transducing factor. EMBO J 13 6 (1994) 1350-1356
7. Hou J., Schindler U., Henzel W.J., Ho T.C., Brasseur M., and McKnight S.L. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265 5179 (1994) 1701-1706
8. Quelle F.W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S.M., et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 15 6 (1995) 3336-3343
9. Copeland N.G., Gilbert D.J., Schindler C., Zhong Z., Wen Z., Darnell Jr. J.E., et al. Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics 29 1 (1995) 225-228
10. Svaren J., Apel E.D., Simburger K.S., Jenkins N.A., Gilbert D.J., Copeland N.A., et al. The Nab2 and Stat6 genes share a common transcription termination region. Genomics 41 1 (1997) 33-39
11. Patel B.K., Keck C.L., O'Leary R.S., Popescu N.C., and LaRochelle W.J. Localization of the human stat6 gene to chromosome 12q13.3-q14.1, a region implicated in multiple solid tumors. Genomics 52 2 (1998) 192-200
12. Patel B.K., Pierce J.H., and LaRochelle W.J. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6. Proc Natl Acad Sci USA 95 1 (1998) 172-177
13. Arinobu Y., Sugimoto R., Akaiwa M., Arima K., Otsuka T., Hamasaki N., et al. Augmentation of signal transducer and activation of transcription (STAT)6 and STAT3 expression in stimulated B and T cells. Biochem Biophys Res Commun 277 2 (2000) 317-324
14. Pykalainen M., Kinos R., Valkonen S., Rydman P., Kilpelainen M., Laitinen L.A., et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol 115 1 (2005) 80-87
15. Schindler U., Wu P., Rothe M., Brasseur M., and McKnight S.L. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2 6 (1995) 689-697
16. Mikita T., Campbell D., Wu P., Williamson K., and Schindler U. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol Cell Biol 16 10 (1996) 5811-5820
17. Mikita T., Daniel C., Wu P., and Schindler U. Mutational analysis of the STAT6 SH2 domain. J Biol Chem 273 28 (1998) 17634-17642
18. Hoey T., and Schindler U. STAT structure and function in signaling. Curr Opin Genet Dev 8 5 (1998) 582-587
19. Lu B., Reichel M., Fisher D.A., Smith J.F., and Rothman P. Identification of a STAT6 domain required for IL-4-induced activation of transcription. J Immunol 159 3 (1997) 1255-1264
20. Moriggl R., Berchtold S., Friedrich K., Standke G.J., Kammer W., Heim M., et al. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol Cell Biol 17 7 (1997) 3663-3678
21. Chen X., Vinkemeier U., Zhao Y., Jeruzalmi D., Darnell Jr. J.E., and Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93 5 (1998) 827-839
22. Becker S., Groner B., and Muller C.W. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394 6689 (1998) 145-151
23. Braunstein J., Brutsaert S., Olson R., and Schindler C. STATs dimerize in the absence of phosphorylation. J Biol Chem 278 36 (2003) 34133-34140
24. Ota N., Brett T.J., Murphy T.L., Fremont D.H., and Murphy K.M. N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat Immunol 5 2 (2004) 208-215
25. Zhong M., Henriksen M.A., Takeuchi K., Schaefer O., Liu B., ten Hoeve J., et al. Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. Proc Natl Acad Sci USA 102 11 (2005) 3966-3971
26. Hershey G.K. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111 4 (2003) 677-690 [quiz 691]
27. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., and Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17 (1999) 701-738
28. Galizzi J.P., Zuber C.E., Harada N., Gorman D.M., Djossou O., Kastelein R., et al. Molecular cloning of a cDNA encoding the human interleukin 4 receptor. Int Immunol 2 7 (1990) 669-675
29. Mueller T.D., Zhang J.L., Sebald W., and Duschl A. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta 1592 3 (2002) 237-250
30. Pernis A., Witthuhn B., Keegan A.D., Nelms K., Garfein E., Ihle J.N., et al. Interleukin 4 signals through two related pathways. Proc Natl Acad Sci USA 92 17 (1995) 7971-7975
31. Ryan J.J., McReynolds L.J., Keegan A., Wang L.H., Garfein E., Rothman P., et al. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4 2 (1996) 123-132
32. Wang H.Y., Paul W.E., and Keegan A.D. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 4 2 (1996) 113-121
33. Stolzenberger S., Haake M., and Duschl A. Specific inhibition of interleukin-4-dependent Stat6 activation by an intracellularly delivered peptide. Eur J Biochem 268 17 (2001) 4809-4814
34. Mora A.L., Stephenson L.M., Enerson B., Youn J., Keegan A.D., and Boothby M. New programming of IL-4 receptor signal transduction in activated T cells: Stat6 induction and Th2 differentiation mediated by IL-4Ralpha lacking cytoplasmic tyrosines. J Immunol 171 4 (2003) 1891-1900
35. Karras J.G., Wang Z., Coniglio S.J., Frank D.A., and Rothstein T.L. Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-gamma activation site. J Immunol 157 1 (1996) 39-47
36. Schmidt-Weber C.B., Rao A., and Lichtman A.H. Integration of TCR and IL-4 signals through STAT6 and the regulation of IL-4 gene expression. Mol Immunol 37 12-13 (2000) 767-774
37. Karras J.G., Wang Z., Huo L., Frank D.A., and Rothstein T.L. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J Immunol 159 9 (1997) 4350-4355
38. Oki S., Otsuki N., Kohsaka T., and Azuma M. Stat6 activation and Th2 cell differentiation [correction of proliferation] driven by CD28 [correction of CD28 signals]. Eur J Immunol 30 5 (2000) 1416-1424
39. McInnes I.B., and Gracie J.A. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 4 4 (2004) 392-397
40. Masuda A., Matsuguchi T., Yamaki K., Hayakawa T., Kubo M., LaRochelle W.J., et al. Interleukin-15 induces rapid tyrosine phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells. J Biol Chem 275 38 (2000) 29331-29337
41. Masuda A., Matsuguchi T., Yamaki K., Hayakawa T., and Yoshikai Y. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J Biol Chem 276 28 (2001) 26107-26113
42. Bulanova E., Budagian V., Orinska Z., Krause H., Paus R., and Bulfone-Paus S. Mast cells express novel functional IL-15 receptor alpha isoforms. J Immunol 170 10 (2003) 5045-5055
43. Qin J.Z., Kamarashev J., Zhang C.L., Dummer R., Burg G., and Dobbeling U. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol 117 3 (2001) 583-589
44. Qin J.Z., Zhang C.L., Kamarashev J., Dummer R., Burg G., and Dobbeling U. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood 98 9 (2001) 2778-2783
45. Patel B.K., Wang L.M., Lee C.C., Taylor W.G., Pierce J.H., and LaRochelle W.J. Stat6 and Jak1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts. J Biol Chem 271 36 (1996) 22175-22182
46. Hua K., Deng J., and Harp J.B. Interleukin-4 inhibits platelet-derived growth factor-induced preadipocyte proliferation. Cytokine 25 2 (2004) 61-67
47. Kriebel P., Patel B.K., Nelson S.A., Grusby M.J., and LaRochelle W.J. Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts. Oncogene 18 51 (1999) 7294-7302
48. Ingram J.L., Rice A.B., Geisenhoffer K., Madtes D.K., and Bonner J.C. IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha. FASEB J 18 10 (2004) 1132-1134
49. Hundley T.R., Gilfillan A.M., Tkaczyk C., Andrade M.V., Metcalfe D.D., and Beaven M.A. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104 8 (2004) 2410-2417
50. Mascareno E., Dhar M., and Siddiqui M.A. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci USA 95 10 (1998) 5590-5594
51. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., and Skoda R.C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 93 13 (1996) 6231-6235
52. Fasler-Kan E., Pansky A., Wiederkehr M., Battegay M., and Heim M.H. Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells. Eur J Biochem 254 3 (1998) 514-519
53. Gupta S., Jiang M., and Pernis A.B. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. J Immunol 163 7 (1999) 3834-3841
54. Kashiwada M., Giallourakis C.C., Pan P.Y., and Rothman P.B. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation. J Immunol 167 11 (2001) 6382-6387
55. Haque S.J., Harbor P., Tabrizi M., Yi T., and Williams B.R. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J Biol Chem 273 51 (1998) 33893-33896
56. Hanson E.M., Dickensheets H., Qu C.K., Donnelly R.P., and Keegan A.D. Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome. J Biol Chem 278 6 (2003) 3903-3911
57. White E.D., Andrews R.P., and Hershey G.K. Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells. J Leukoc Biol 69 5 (2001) 825-830
58. Huang Z., Coleman J.M., Su Y., Mann M., Ryan J., Shultz L.D., et al. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner. Cytokine 29 3 (2005) 118-124
59. Andrews R.P., Ericksen M.B., Cunningham C.M., Daines M.O., and Hershey G.K. Analysis of the life cycle of stat6. Continuous cycling of STAT6 is required for IL-4 signaling. J Biol Chem 277 39 (2002) 36563-36569
60. Craggs G., and Kellie S. A functional nuclear localization sequence in the C-terminal domain of SHP-1. J Biol Chem 276 26 (2001) 23719-23725
61. Pesu M., Takaluoma K., Aittomaki S., Lagerstedt A., Saksela K., Kovanen P.E., et al. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6. Blood 95 2 (2000) 494-502
62. Wick K.R., and Berton M.T. IL-4 induces serine phosphorylation of the STAT6 transactivation domain in B lymphocytes. Mol Immunol 37 11 (2000) 641-652
63. Wang Y., Malabarba M.G., Nagy Z.S., and Kirken R.A. Interleukin 4 regulates phosphorylation of serine 756 in the transactivation domain of Stat6. Roles for multiple phosphorylation sites and Stat6 function. J Biol Chem 279 24 (2004) 25196-25203
64. Woetmann A., Brockdorff J., Lovato P., Nielsen M., Leick V., Rieneck K., et al. Protein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signaling. J Biol Chem 278 5 (2003) 2787-2791
65. McDonald C., and Reich N.C. Cooperation of the transcriptional coactivators CBP and p300 with Stat6. J Interferon Cytokine Res 19 7 (1999) 711-722
66. Shankaranarayanan P., Chaitidis P., Kuhn H., and Nigam S. Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J Biol Chem 276 46 (2001) 42753-42760
67. Mowen K.A., Tang J., Zhu W., Schurter B.T., Shuai K., Herschman H.R., et al. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104 5 (2001) 731-741
68. Chen W., Daines M.O., and Hershey G.K. Methylation of STAT6 modulates STAT6 phosphorylation, nuclear translocation, and DNA-binding activity. J Immunol 172 11 (2004) 6744-6750
69. Gewinner C., Hart G., Zachara N., Cole R., Beisenherz-Huss C., and Groner B. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J Biol Chem 279 5 (2004) 3563-3572
70. Sherman M.A., Secor V.H., and Brown M.A. IL-4 preferentially activates a novel STAT6 isoform in mast cells. J Immunol 162 5 (1999) 2703-2708
71. Suzuki K., Nakajima H., Kagami S., Suto A., Ikeda K., Hirose K., et al. Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. J Exp Med 196 1 (2002) 27-38
72. Shelburne C.P., Piekorz R.P., Bouton L.A., Chong H.J., and Ryan J.J. Mast cell-restricted p70 Stat6 isoform is a product of selective proteolysis. Cytokine 19 5 (2002) 218-227
73. Sherman M.A., Powell D.R., and Brown M.A. IL-4 induces the proteolytic processing of mast cell STAT6. J Immunol 169 7 (2002) 3811-3818
74. Suzuki K., Nakajima H., Ikeda K., Tamachi T., Hiwasa T., Saito Y., et al. Stat6-protease but not Stat5-protease is inhibited by an elastase inhibitor ONO-5046. Biochem Biophys Res Commun 309 4 (2003) 768-773
75. Zamorano J., Rivas M.D., Setien F., and Perez G.M. Proteolytic regulation of activated STAT6 by calpains. J Immunol 174 5 (2005) 2843-2848
76. Wang D., Moriggl R., Stravopodis D., Carpino N., Marine J.C., Teglund S., et al. A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5. EMBO J 19 3 (2000) 392-399
77. Tang X., Marciano D.L., Leeman S.E., and Amar S. LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci USA 102 14 (2005) 5132-5137
78. Daines M.O., Andrews R.P., Chen W., El-Zayaty S.A., and Hershey G.K. DNA binding activity of cytoplasmic phosphorylated Stat6 is masked by an interaction with a detergent-sensitive factor. J Biol Chem 278 33 (2003) 30971-30974
79. McBride K.M., Banninger G., McDonald C., and Reich N.C. Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha. EMBO J 21 7 (2002) 1754-1763
80. Lee C.E., and Park H.J. Interleukin-4 induces two distinct GAS-binding complexes containing STAT6: evidence for DNA binding of STAT6 monomer. Mol Cells 11 1 (2001) 28-34
81. Hebenstreit D., Luft P., Schmiedlechner A., Regl G., Frischauf A.M., Aberger F., et al. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J Immunol 171 11 (2003) 5901-5907
82. Seidel H.M., Milocco L.H., Lamb P., Darnell Jr. J.E., Stein R.B., and Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 92 7 (1995) 3041-3045
83. Ehret G.B., Reichenbach P., Schindler U., Horvath C.M., Fritz S., Nabholz M., et al. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 276 9 (2001) 6675-6688
84. Kraus J., Borner C., and Hollt V. Distinct palindromic extensions of the 5′-TTC...GAA-3′ motif allow STAT6 binding in vivo. FASEB J 17 2 (2003) 304-306
85. Delphin S., and Stavnezer J. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF-IL-4, a C/EBP family member and NF-kappa B/p50. J Exp Med 181 1 (1995) 181-192
86. Hoeck J., and Woisetschlager M. Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 167 6 (2001) 3216-3222
87. Goenka S., Marlar C., Schindler U., and Boothby M. Differential roles of C-terminal activation motifs in the establishment of Stat6 transcriptional specificity. J Biol Chem 278 50 (2003) 50362-50370
88. Ohmori Y., and Hamilton T.A. STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J Biol Chem 273 44 (1998) 29202-29209
89. Gingras S., Simard J., Groner B., and Pfitzner E. p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res 27 13 (1999) 2722-2729
90. Valineva T., Yang J., Palovuori R., and Silvennoinen O. The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. J Biol Chem 280 15 (2005) 14989-14996
91. Yang J., Aittomaki S., Pesu M., Carter K., Saarinen J., Kalkkinen N., et al. Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. EMBO J 21 18 (2002) 4950-4958
92. Arimura A., vn Peer M., Schroder A.J., and Rothman P.B. The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6. J Biol Chem 279 30 (2004) 31105-31112
93. Litterst C.M., and Pfitzner E. Transcriptional activation by STAT6 requires the direct interaction with NCoA-1. J Biol Chem 276 49 (2001) 45713-45721
94. Litterst C.M., and Pfitzner E. An LXXLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/SRC-1. J Biol Chem 277 39 (2002) 36052-36060
95. Razeto A., Ramakrishnan V., Litterst C.M., Giller K., Griesinger C., Carlomagno T., et al. Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain. J Mol Biol 336 2 (2004) 319-329
96. Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365 Pt 3 (2002) 561-575
97. Lundgren M., Larsson C., Femino A., Xu M., Stavnezer J., and Severinson E. Activation of the Ig germ-line gamma 1 promoter. Involvement of C/enhancer-binding protein transcription factors and their possible interaction with an NF-IL-4 site. J Immunol 153 7 (1994) 2983-2995
98. Mikita T., Kurama M., and Schindler U. Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta. J Immunol 161 4 (1998) 1822-1828
99. Pan Q., Petit-Frere C., Stavnezer J., and Hammarstrom L. Regulation of the promoter for human immunoglobulin gamma3 germ-line transcription and its interaction with the 3'alpha enhancer. Eur J Immunol 30 4 (2000) 1019-1029
100. Shen C.H., and Stavnezer J. Activation of the mouse Ig germline epsilon promoter by IL-4 is dependent on AP-1 transcription factors. J Immunol 166 1 (2001) 411-423
101. Stutz A.M., Pickart L.A., Trifilieff A., Baumruker T., Prieschl-Strassmayr E., and Woisetschlager M. The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism. J Immunol 170 4 (2003) 1789-1796
102. Pauleau A.L., Rutschman R., Lang R., Pernis A., Watowich S.S., and Murray P.J. Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol 172 12 (2004) 7565-7573
103. Gray M.J., Poljakovic M., Kepka-Lenhart D., and Morris Jr. S.M. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene 353 1 (2005) 98-106
104. Ezernieks J., Schnarr B., Metz K., and Duschl A. The human IgE germline promoter is regulated by interleukin-4, interleukin-13, interferon-alpha and interferon-gamma via an interferon-gamma-activated site and its flanking regions. Eur J Biochem 240 3 (1996) 667-673
105. Tinnell S.B., Jacobs-Helber S.M., Sterneck E., Sawyer S.T., and Conrad D.H. STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production. Int Immunol 10 10 (1998) 1529-1538
106. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 6 (2004) 280-288
107. Matsukura S., Stellato C., Plitt J.R., Bickel C., Miura K., Georas S.N., et al. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 163 12 (1999) 6876-6883
108. Bennett B.L., Cruz R., Lacson R.G., and Manning A.M. Interleukin-4 suppression of tumor necrosis factor alpha-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-kappaB. J Biol Chem 272 15 (1997) 10212-10219
109. Shen C.H., and Stavnezer J. Interaction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription. Mol Cell Biol 18 6 (1998) 3395-3404
110. Ohmori Y., and Hamilton T.A. Interleukin-4/STAT6 represses STAT1 and NF-kappa B-dependent transcription through distinct mechanisms. J Biol Chem 275 48 (2000) 38095-38103
111. Abu-Amer Y. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB. J Clin Invest 107 11 (2001) 1375-1385
112. Wei S., Wang M.W., Teitelbaum S.L., and Ross F.P. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling. J Biol Chem 277 8 (2002) 6622-6630
113. Nelson G., Wilde G.J., Spiller D.G., Kennedy S.M., Ray D.W., Sullivan E., et al. NF-kappaB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms. J Cell Sci 116 Pt 12 (2003) 2495-2503
114. Biola A., Andreau K., David M., Sturm M., Haake M., Bertoglio J., et al. The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes. FEBS Lett 487 2 (2000) 229-233
115. Franchimont D., Galon J., Gadina M., Visconti R., Zhou Y., Aringer M., et al. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol 164 4 (2000) 1768-1774
116. Heller N.M., Matsukura S., Georas S.N., Boothby M.R., Stellato C., and Schleimer R.P. Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells. Clin Exp Allergy 34 11 (2004) 1690-1700
117. Oikawa T. ETS transcription factors: possible targets for cancer therapy. Cancer Sci 95 8 (2004) 626-633
118. Travagli J., Letourneur M., Bertoglio J., and Pierre J. STAT6 and Ets-1 form a stable complex that modulates Socs-1 expression by interleukin-4 in keratinocytes. J Biol Chem 279 34 (2004) 35183-35192
119. Stutz A.M., and Woisetschlager M. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription. J Immunol 163 8 (1999) 4383-4391
120. Pesu M., Aittomaki S., Valineva T., and Silvennoinen O. PU.1 is required for transcriptional activation of the Stat6 response element in the Igepsilon promoter. Eur J Immunol 33 6 (2003) 1727-1735
121. Dent A.L., Shaffer A.L., Yu X., Allman D., and Staudt L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276 5312 (1997) 589-592
122. Fukuda T., Yoshida T., Okada S., Hatano M., Miki T., Ishibashi K., et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 186 3 (1997) 439-448
123. Ye B.H., Cattoretti G., Shen Q., Zhang J., Hawe N., de Waard R., et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16 2 (1997) 161-170
124. Harris M.B., Chang C.C., Berton M.T., Danial N.N., Zhang J., Kuehner D., et al. Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol Cell Biol 19 10 (1999) 7264-7275
125. Harris M.B., Mostecki J., and Rothman P.B. Repression of an interleukin-4-responsive promoter requires cooperative BCL-6 function. J Biol Chem 280 13 (2005) 13114-13121
126. Dent A.L., Hu-Li J., Paul W.E., and Staudt L.M. T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc Natl Acad Sci USA 95 23 (1998) 13823-13828
127. Hartatik T., Okada S., Okabe S., Arima M., Hatano M., and Tokuhisa T. Binding of BAZF and Bc16 to STAT6-binding DNA sequences. Biochem Biophys Res Commun 284 1 (2001) 26-32
128. Mittrucker H.W., Matsuyama T., Grossman A., Kundig T.M., Potter J., Shahinian A., et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275 5299 (1997) 540-543
129. Gupta S., Jiang M., Anthony A., and Pernis A.B. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J Exp Med 190 12 (1999) 1837-1848
130. Monticelli S., Ghittoni R., Kabesch M., and Vercelli D. Myb proteins repress human Ig epsilon germline transcription by inhibiting STAT6-dependent promoter activation. Mol Immunol 38 15 (2002) 1129-1138
131. Schroder A.J., Pavlidis P., Arimura A., Capece D., and Rothman P.B. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J Immunol 168 3 (2002) 996-1000
132. Welch J.S., Escoubet-Lozach L., Sykes D.B., Liddiard K., Greaves D.R., and Glass C.K. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem 277 45 (2002) 42821-42829
133. Chen Z., Lund R., Aittokallio T., Kosonen M., Nevalainen O., and Lahesmaa R. Identification of novel IL-4/Stat6-regulated genes in T lymphocytes. J Immunol 171 7 (2003) 3627-3635
134. Zimmermann N., Mishra A., King N.E., Fulkerson P.C., Doepker M.P., Nikolaidis N.M., et al. Transcript signatures in experimental asthma: identification of STAT6-dependent and -independent pathways. J Immunol 172 3 (2004) 1815-1824
135. Finkelman F.D., Yang M., Perkins C., Schleifer K., Sproles A., Santeliz J., et al. Suppressive effect of IL-4 on IL-13-induced genes in mouse lung. J Immunol 174 8 (2005) 4630-4638
136. Nguyen V.T., and Benveniste E.N. IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia. J Immunol 165 11 (2000) 6235-6243
137. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., et al. Essential role of Stat6 in IL-4 signalling. Nature 380 6575 (1996) 627-630
138. Palmer-Crocker R.L., Hughes C.C., and Pober J.S. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J Clin Invest 98 3 (1996) 604-609
139. Walker C., Bode E., Boer L., Hansel T.T., Blaser K., and Virchow Jr. J.C. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 146 1 (1992) 109-115
140. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326 5 (1992) 298-304
141. Robinson D.S., Hamid Q., Jacobson M., Ying S., Kay A.B., and Durham S.R. Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Semin Immunopathol 15 1 (1993) 17-27
142. Swain S.L., Weinberg A.D., English M., and Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 145 11 (1990) 3796-3806
143. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380 6575 (1996) 630-633
144. Kaplan M.H., Schindler U., Smiley S.T., and Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4 3 (1996) 313-319
145. Zhu J., Guo L., Watson C.J., Hu-Li J., and Paul W.E. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol 166 12 (2001) 7276-7281
146. Urban Jr. J.F., Schopf L., Morris S.C., Orekhova T., Madden K.B., Betts C.J., et al. Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J Immunol 164 4 (2000) 2046-2052
147. Spencer L., Shultz L., and Rajan T.V. Interleukin-4 receptor-Stat6 signaling in murine infections with a tissue-dwelling nematode parasite. Infect Immun 69 12 (2001) 7743-7752
148. Khan W.I., Blennerhasset P., Ma C., Matthaei K.I., and Collins S.M. Stat6 dependent goblet cell hyperplasia during intestinal nematode infection. Parasite Immunol 23 1 (2001) 39-42
149. Madden K.B., Whitman L., Sullivan C., Gause W.C., Urban Jr. J.F., Katona I.M., et al. Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol 169 8 (2002) 4417-4422
150. Madden K.B., Yeung K.A., Zhao A., Gause W.C., Finkelman F.D., Katona I.M., et al. Enteric nematodes induce stereotypic STAT6-dependent alterations in intestinal epithelial cell function. J Immunol 172 9 (2004) 5616-5621
151. Akimoto T., Numata F., Tamura M., Takata Y., Higashida N., Takashi T., et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J Exp Med 187 9 (1998) 1537-1542
152. Malaviya R., and Uckun F.M. Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allergic responses of mast cells. J Immunol 168 1 (2002) 421-426
153. Sallusto F., Lanzavecchia A., and Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19 12 (1998) 568-574
154. Humbles A.A., Lu B., Friend D.S., Okinaga S., Lora J., Al-Garawi A., et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci USA 99 3 (2002) 1479-1484
155. Hoeck J., and Woisetschlager M. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. J Immunol 166 7 (2001) 4507-4515
156. Mathew A., MacLean J.A., DeHaan E., Tager A.M., Green F.H., and Luster A.D. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 193 9 (2001) 1087-1096
157. Fulkerson P.C., Zimmermann N., Hassman L.M., Finkelman F.D., and Rothenberg M.E. Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-gamma. J Immunol 173 12 (2004) 7565-7574
158. Sakamoto O., Hashiyama M., Minty A., Ando M., and Suda T. Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood 85 12 (1995) 3487-3493
159. Takeda K., Kamanaka M., Tanaka T., Kishimoto T., and Akira S. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 157 8 (1996) 3220-3222
160. Kobayashi M., Kobayashi H., Pollard R.B., and Suzuki F. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol 160 12 (1998) 5869-5873
161. Bellone G., Turletti A., Artusio E., Mareschi K., Carbone A., Tibaudi D., et al. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol 155 2 (1999) 537-547
162. Ostrand-Rosenberg S., Grusby M.J., and Clements V.K. Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma. J Immunol 165 11 (2000) 6015-6019
163. Ostrand-Rosenberg S., Sinha P., Clements V., Dissanayake S.I., Miller S., Davis C., et al. Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease. Cancer Immunol Immunother 53 2 (2004) 86-91
164. Conrad D.J., and Lu M. Regulation of human 12/15-lipoxygenase by Stat6-dependent transcription. Am J Respir Cell Mol Biol 22 2 (2000) 226-234
165. Gingras S., and Simard J. Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines. Endocrinology 140 10 (1999) 4573-4584
166. Buttner C., Skupin A., and Rieber E.P. Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences. J Cell Physiol 198 2 (2004) 248-258
167. Dedeoglu F., Horwitz B., Chaudhuri J., Alt F.W., and Geha R.S. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int Immunol 16 3 (2004) 395-404
168. McHugh K.P., Kitazawa S., Teitelbaum S.L., and Ross F.P. Cloning and characterization of the murine beta(3) integrin gene promoter: identification of an interleukin-4 responsive element and regulation by STAT-6. J Cell Biochem 81 2 (2001) 320-332
169. Borner C., Woltje M., Hollt V., and Kraus J. STAT6 transcription factor binding sites with mismatches within the canonical 5′-TTC...GAA-3′ motif involved in regulation of delta- and mu-opioid receptors. J Neurochem 91 6 (2004) 1493-1500
170. Schaffer A., Cerutti A., Shah S., Zan H., and Casali P. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites. J Immunol 162 9 (1999) 5327-5336
171. David M.D., Bertoglio J., and Pierre J. Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression. Oncogene 22 22 (2003) 3386-3394
172. Kubo M., Ransom J., Webb D., Hashimoto Y., Tada T., and Nakayama T. T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J 16 13 (1997) 4007-4020
173. Curiel R.E., Lahesmaa R., Subleski J., Cippitelli M., Kirken R.A., Young H.A., et al. Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene. Eur J Immunol 27 8 (1997) 1982-1987
174. Kotanides H., and Reich N.C. Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J Biol Chem 271 41 (1996) 25555-25561
175. Worm M.M., Tsytsykova A., and Geha R.S. CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells. Eur J Immunol 28 3 (1998) 901-906
176. Kraus J., Borner C., Giannini E., Hickfang K., Braun H., Mayer P., et al. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 276 47 (2001) 43901-43908
177. Schjerven H., Brandtzaeg P., and Johansen F.E. Mechanism of IL-4-mediated up-regulation of the polymeric Ig receptor: role of STAT6 in cell type-specific delayed transcriptional response. J Immunol 165 7 (2000) 3898-3906
178. Khew-Goodall Y., Wadham C., Stein B.N., Gamble J.R., and Vadas M.A. Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 19 6 (1999) 1421-1429
179. Lee D.U., and Rao A. Molecular analysis of a locus control region in the T helper 2 cytokine gene cluster: a target for STAT6 but not GATA3. Proc Natl Acad Sci USA 101 45 (2004) 16010-16015
180. Ohmori Y., Smith Jr. M.F., and Hamilton T.A. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 157 5 (1996) 02058-02065
181. Blanchard C., Durual S., Estienne M., Bouzakri K., Heim M.H., Blin N., et al. IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis. J Immunol 172 6 (2004) 3775-3783
182. Agresti A., and Vercelli D. c-Rel is a selective activator of a novel IL-4/CD40 responsive element in the human Ig gamma4 germline promoter. Mol Immunol 38 11 (2002) 849-859